Clinical Trial Update: Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative Pathology [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating different postoperative adjuvant regimens after radical surgery for resectable gastric or gastroesophageal junction adenocarcinoma foll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Gastric / Gastroesophageal Junction Adenocarcinoma | Phase 4 | Status: NOT_YET_RECRUITING